Latest News

First Horizon (FHN) has come into its Q1 2026 earnings season following a solid 2025 finish, with Q4 revenue of US$888 million, basic EPS of US$0.52 and net income of US$257 million setting the tone against a trailing twelve month backdrop that includes 29.5% earnings growth and net profit margins of 28.5%. Over the last few quarters, revenue has moved from US$718 million in Q4 2024 to US$888 million in Q4 2025, while quarterly EPS stepped from US$0.30 to US$0.52 and trailing twelve month EPS...

Wondering if Bayerische Motoren Werke is trading at a fair price, or if the current share price is giving you an opportunity or extra risk to think about? The stock last closed at €82.24, with a 4.0% gain over 30 days, a 23.1% return over 1 year, but a 14.6% decline year to date. Recent moves in the share price sit against a backdrop of ongoing attention on established auto manufacturers and their positioning in areas such as electrification, premium branding and global production...

Sprinklr (NYSE:CXM) has rolled out its Spring ’26 Release, adding new AI capabilities across its unified customer experience platform. The update introduces expanded Copilot tools, deeper voice of customer analytics, and new automation features for marketing and service teams. Spring ’26 also brings more advanced governance controls and integrations with popular content and asset platforms for enterprise users. Sprinklr focuses on helping large enterprises manage customer interactions...

SunPower FY 2025 earnings snapshot SunPower (SPWR) has just wrapped up FY 2025 with Q4 revenue of about US$79.7 million and a basic EPS loss of US$0.14, setting a cautious tone around profitability even as top line activity continues. Over the recent quarters, revenue has moved from US$88.7 million in Q4 2024 to US$82.7 million in Q1 2025, US$67.5 million in Q2 2025 and US$70.0 million in Q3 2025, before reaching US$79.7 million in Q4. EPS shifted from a profit of US$0.58 in Q4 2024 to mixed...

If you are wondering whether Cameco's current share price reflects its true worth, this article walks through the key signals you can use to judge the stock's value for yourself. Cameco's share price recently closed at $163.76, with returns of 2.0% over 7 days, 8.5% over 30 days, 21.0% year to date, 186.6% over 1 year, 379.3% over 3 years, and a very large 5 year return that is roughly 7x. Recent coverage has focused on Cameco in the context of uranium and nuclear related themes, which has...

CarMax FY 2026 earnings snapshot CarMax (KMX) has just closed out FY 2026 with fourth quarter revenue of US$6.4b, a basic EPS loss of US$0.85 and net income of US$120.7m in the red, alongside a 2% same store sales decline. This puts a clear spotlight on margins. Over the year, quarterly revenue has moved from US$8.0b in Q1 2026 to US$6.4b in Q4 2026, while basic EPS has ranged from US$1.38 in Q1 to a loss of US$0.85 in Q4. Trailing twelve month EPS stands at US$1.68 and net income at...

Cintas (CTAS) is back on investors' radar after recent share price moves, with the stock down over the past month and past 3 months. This has prompted a closer look at current valuation and business performance. See our latest analysis for Cintas. The recent pullback stands out against a longer record, with a 30 day share price return showing an 8.45% decline and a year to date share price return showing a 4.55% decline. Meanwhile, the 3 year total shareholder return of 59.48% and 5 year...

Deep Yellow has reported ongoing progress at its Tumas uranium project in Namibia, including bulk earthworks, detailed engineering and key power and water supply arrangements, while also advancing studies and exploration across its Australian portfolio at Mulga Rock and Alligator River under a new CEO appointed in February 2026. An important insight is that Deep Yellow is positioning Tumas and Mulga Rock as multi-asset, multi-metal developments, potentially broadening future revenue drivers...

Hansoh Pharmaceutical Group (SEHK:3692) has secured NMPA approval for XINYUE’s third indication, targeting adult patients with generalized myasthenia gravis, and expanding its rare autoimmune disease footprint supported by positive Phase III MINT trial data. See our latest analysis for Hansoh Pharmaceutical Group. The XINYUE approval lands at a time when the share price has climbed to HK$39.4, with a 30 day share price return of 21.6% and a 1 year total shareholder return of 82.34%. This...

SAP (XTRA:SAP) has introduced a native direct to core payment integration with BlueSnap for SAP Cloud ERP and S/4HANA. The new integration removes the need for third party payment connectors and is available as a certified solution for SAP enterprise customers. The launch is aimed at simplifying global payment processing, reconciliation, and compliance for multinational operations. SAP, trading at €146.54, is moving to tighten the link between its core ERP platforms and global payment flows...

If you are wondering whether Sterling Infrastructure's current share price still offers value after a strong run, the key is to look closely at what the market might already be pricing in. The stock closed at US$456.08, with returns of 7.7% over 7 days, 9.2% over 30 days, 42.9% year to date and 224.8% over 1 year. This naturally raises questions about how much optimism is now embedded in the price and whether risk perceptions have shifted. Recent attention around Sterling Infrastructure has...

Avarda Bank (OM:AVARDA) opened Q1 2026 with total revenue of SEK 536.8 million and basic EPS of SEK 3.17, while on a trailing twelve month basis revenue stood at SEK 2.0 billion and EPS at SEK 10.94, as the bank continued to convert top line into earnings. The company has seen quarterly revenue move from SEK 607.8 million in Q4 2024 to SEK 436.9 million in Q1 2025, then to SEK 536.8 million in Q1 2026, with basic EPS shifting from SEK 3.68 to SEK 2.15 and now SEK 3.17 over the same points...

Progressive (PGR) opened 2026 with solid momentum, coming off Q4 2025 revenue of about US$22.7b and basic EPS of US$5.03, backed by trailing 12 month figures of US$87.6b in revenue and EPS of US$19.29, alongside year over year earnings growth of 33.6%. Over the past reported periods, revenue has moved from roughly US$20.3b in Q4 2024 to US$22.7b in Q4 2025, while quarterly EPS ranged between about US$3.99 and US$5.42. This sets up a story where margin trends and underwriting performance take...

AIXTRON recently raised its full-year 2026 guidance after reporting about 30% year-on-year growth in first-quarter order intake, driven mainly by strong demand for its optoelectronics equipment used in AI-related semiconductor production. Despite some short-term pressure on gross profit and operating result, the company now targets around €560 million in 2026 revenue with an EBIT margin of roughly 17% to 20%, underscoring how AI infrastructure spending is reshaping demand for its compound...

Samsung Electronics (KOSE:A005930) is using its Galaxy S26 Ultra to capture immersive point of view footage at the Street League Skateboarding DTLA Takeover event. The same smartphone platform is set to support live sports broadcasting at the Olympic Winter Games Milano Cortina 2026. The initiative focuses on skater level and athlete level camera angles, using consumer devices in professional broadcast setups. For you as an investor, this sits at the crossroads of Samsung Electronics' core...

Smith-Midland (SMID) has wrapped up FY 2025 with fourth quarter revenue of US$23.1 million and net income of US$2.1 million, translating to EPS of US$0.40 and rounding out a trailing 12 month EPS figure of US$2.36 on revenue of US$93.4 million. Over recent quarters the company has seen revenue move from US$18.5 million in Q4 FY 2024 to US$23.1 million in Q4 FY 2025, while quarterly EPS over the same period went from US$0.26 to US$0.40. This gives a clear sense of how the top line and per...

FMC (FMC) is in focus after announcing European Union regulatory approval for its herbicide molecule Isoflex active. This marks a key step toward commercializing products across more than 55 million hectares of major crops. See our latest analysis for FMC. FMC's recent Isoflex active approval comes after a sharp 26.23% 1 month share price return and 21.48% year to date gain. However, the 1 year total shareholder return of 51.26% and 5 year total shareholder return of 82.25% indicate that...

Why Pentair is on investors’ radar today Pentair (PNR) has attracted fresh attention after recent trading left the shares with mixed short term performance, including a 3 month return of about a 17% decline and a 1 year total return of 10.6%. See our latest analysis for Pentair. The recent 17.4% 3 month share price decline, alongside a 16.2% negative year to date share price return, contrasts with Pentair’s 10.6% 1 year total shareholder return. This suggests fading short term momentum...

If you are wondering whether Steven Madden's current share price reflects its underlying worth, or if the market is getting ahead of itself, this article walks through the key signals you can use to judge value for yourself. The stock closed at US$38.38, with returns of 3.1% over 7 days, 19.0% over 30 days, a 9.1% decline year to date, and 101.6% over the last year, which naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Steven...

Vivenio Residencial SOCIMI (BME:YVIV) has put fresh numbers on the table for FY 2025, reporting first half revenue of €37.7 million and basic EPS of €0.064. The trailing twelve months show revenue of €69.5 million and EPS of €0.121 on a share price of €1.35. The company has reported revenue of €28.1 million and EPS of €0.053 in the first half of 2024, followed by €31.8 million in revenue and EPS of €0.057 in the second half. This sets up FY 2025 with a results profile where investors may...

Zscaler (ZS) is back in focus after its shares lagged the broader market over the past month, drawing attention to the upcoming earnings report and what fresh analyst estimate revisions might signal. See our latest analysis for Zscaler. At around US$131 per share, Zscaler has seen strong short term volatility, with a 1 day share price return of 6.79% alongside a 30 day share price return decline of 14.76% and a 1 year total shareholder return decline of 35.42%. This suggests momentum has been...

Artificial intelligence in healthcare sits at the intersection of powerful software and real human need, at a time when energy shocks, uneven inflation and shifting bond markets keep wider assets on edge. While global growth expectations are softer and policy signals are mixed, AI tools that can help clinicians detect disease, personalise treatment and run hospitals more efficiently still speak to long term structural demand. This Transformative AI Healthcare screener is built to surface...

Urban Outfitters (URBN) has announced a new retail partnership with beauty brand Sol de Janeiro, expanding its beauty and wellness assortment and sharpening its focus on categories closely followed by Gen Z shoppers. See our latest analysis for Urban Outfitters. The new Sol de Janeiro tie up lands at a time when Urban Outfitters’ share price has been choppy in the short term, with a 1 day share price return of 3.57% and a 30 day share price return of 5.64%. Yet year to date the share price...

Clinical outcomes data as a potential input for investors LifeStance Health Group (LFST) released new clinical outcomes data covering roughly 180,000 patients across 33 states, reporting clinically significant symptom improvements in anxiety and depression that may interest investors tracking quality of care metrics. According to the company, 79% of patients treated for anxiety and 73% of those treated for depression showed clinically significant improvements based on GAD-7 and PHQ-9...